In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 60 for your search:
Drug:  exemestane
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase IV
Type: Natural history/Epidemiology
Status: Completed
Age: Postmenopausal
Sponsor: Pharmaceutical / Industry
Protocol IDs: A5991089, NCT01047358

2.

Phase: Phase IV
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 11 SEIN 09, NCT01553903

3.

Phase: Phase IV
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CRAD001YGB11, 2012-003689-41, NCT01743560

4.

Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: Postmenopausal
Sponsor: NCI, Other
Protocol IDs: CDR0000456382, ACOSOG-Z1031, CALGB-ACOSOG-Z1031, SDC1, NCT00265759

5.

Phase: Phase III
Type: Treatment
Status: Completed
Age: Postmenopausal
Sponsor: Other
Protocol IDs: EORTC-10951, PHARMACIA-EORTC-10951, NCT00002777

6.

Phase: Phase III
Type: Treatment
Status: Closed
Age: Postmenopausal
Sponsor:
Protocol IDs: ICCG-96OEXE031-C1396-BIG9702, EORTC-10967, FRE-FNCLCC-PACS02/96OEXE031, EU-20013, EU-99002, ICCG-BIG-97/02, NCT00003418

7.

Phase: Phase III
Type: Treatment
Status: Closed
Age: Any age
Sponsor: Other
Protocol IDs: CRC-TU-TEAM, EU-20149, ISRCTN75225940, NCT00032136

8.

Phase: Phase III
Type: Treatment
Status: Closed
Age: Premenopausal
Sponsor: NCI, Other
Protocol IDs: CDR0000316456, IBCSG 24-02, BIG 2-02, CALGB-IBCSG 24-02, CAN-NCIC-IBCSG 24-02, NCCTG-IBCSG 24-02, NSABP-IBCSG 24-02, SWOG-IBCSG 24-02, NABCI-IBCSG 24-02, UCLA-0403024-01, EU-20334, EUDRACT-2004-000166-13, NCT00066690

9.

Phase: Phase III
Type: Treatment
Status: Closed
Age: Premenopausal
Sponsor: NCI, Other
Protocol IDs: IBCSG 25-02, CDR0000316458, BIG-3-02, NABCI-IBCSG-25-02, EU-20347, EUDRACT-2004-000168-28, NCT00066703

10.

Phase: Phase III
Type: Treatment
Status: Closed
Age: Premenopausal
Sponsor: NCI, Other
Protocol IDs: CDR0000318832, IBCSG 26-02, BIG 4-02, NABCI-IBCSG-26-02, EU-20401, 2005-002626-59, EUDRACT-2005-002626-59, NCT00066807

11.

Phase: Phase III
Type: Treatment
Status: Closed
Age: Postmenopausal
Sponsor: Pharmaceutical / Industry
Protocol IDs: 9238IL/0048, EFECT, D6997C00048, NCT00065325

12.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Prevention
Status: Closed
Age: 35 and over
Sponsor: Other
Protocol IDs: MAP3, CAN-NCIC-MAP3, PFIZER-EXEAPO-0028-150, ExCel, CDR0000363802, NCT00083174

13.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 20 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: A5991048, NCT00143390

14.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 50 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 971-ONC-0028-081, A5991026, NCT00036270

15.

Phase: Phase III
Type: Treatment
Status: Closed
Age: Any age
Sponsor: Other
Protocol IDs: CDR0000448616, ICR-CTSU-SOFEA, EU-20531, SSA-04Q200635, ISRCTN44195747, MREC-03677, EUDRACT-2004-000093-30, NCT00253422

16.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 30 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 96-OEXE-031, A5991012, NCT00038467

17.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Tissue collection/Repository, Treatment
Status: Closed
Age: 18 to 75
Sponsor: NCI
Protocol IDs: NCI-2009-00707, CDR0000472066, ECOG-PACCT-1, PACCT-1, U10CA021115, U10CA180820, NCT00310180

18.

Phase: Phase III
Type: Treatment
Status: Unknown
Age: Over 18
Sponsor: Other
Protocol IDs: GIM-3-FATA, GIM3-FATA, EUDRACT-2006-004018-42, EU-20764, NCT00541086

19.

Phase: Phase III
Type: Treatment
Status: Unknown
Age: 18 and over
Sponsor: Other, Pharmaceutical / Industry
Protocol IDs: GIM-GIM8-OVER, GIM8-OVER, EUDRACT-2007-006031-30, EU-20853, GSK-GIM-GIM8-OVER, ZENECA-GIM-GIM8-OVER, OVER, NCT00688194

20.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CRAD001Y2301, 2008-008698-69, NCT00863655

21.

Phase: Phase III
Type: Treatment
Status: Completed
Age: Postmenopausal
Sponsor: Pharmaceutical / Industry
Protocol IDs: 9238UK/0005, NCT00944918

22.

Phase: Phase III
Type: Treatment
Status: Completed
Age: Postmenopausal
Sponsor: NCI, Other
Protocol IDs: NSABP B-33, CDR0000068640, ECOG-NSABP-B-33, NCT00016432

23.

Phase: Phase III
Type: Treatment
Status: Completed
Age: Postmenopausal
Sponsor: NCI, Other
Protocol IDs: MA27, CAN-NCIC-MA27, NCCTG-MA27, CALGB-CAN-NCIC-MA27, ECOG-CAN-NCIC-MA27, SWOG-CAN-NCIC-MA27, IBCSG-30-04, EUDRACT-2005-001893-28, CDR0000316325, CAN-NCIC-MA27-COMPANION, NCIC-MA.27, NCT00066573

24.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Health services research, Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CRAD001JDE49, NCT01626222

25.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Unknown
Age: Postmenopausal
Sponsor: Other
Protocol IDs: ICO-SUT-EXE-08, SUT-EXE-08, PFIZER-ICO-SUT-EXE-08, NCT00931450
1    
New Search